Close Menu
Home » Morphosys, Daiichi Sankyo to Develop Therapeutic Antibodies Against Hospital-Acquired Infections

Morphosys, Daiichi Sankyo to Develop Therapeutic Antibodies Against Hospital-Acquired Infections

Oct 23, 2009
Premium

This story originally ran on Oct. 21.

German antibody firm Morphosys announced this week a collaboration with Japanese pharma Daiichi Sankyo for the development of therapeutic antibodies against hospital-acquired infections.

Daiichi Sankyo becomes Morphosys's first collaborator using Morphosys' HuCAL Platinum antibody library for new drug discovery in infectious diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

So, So Many

According to Gizmodo, researchers have developed a list of a million nucleic acid-like polymers that could store genetic information.

Golden Rice Soon?

An opinion piece in the Washington Post argues that golden rice could save the sight and lives of many children.

To Share More

US National Institutes of Health has issued a new draft data-sharing policy, ScienceInsider reports.

Cell Studies Assess Hepatocellular Carcinoma Immune Cells, Renal Cell Carcinoma, More

In Cell this week: analysis of immune microenvironment in hepatocellular carcinoma, proteogenomic analysis of clear cell renal cell carcinoma, and more.

Nov
18
Featured Webinar

Simultaneous Single-Cell DNA and Protein Sequencing in AML Samples

Sponsored by
Mission Bio

This webinar will outline the results of a study that performed integrative single-cell genome and cell surface protein expression profiling of adult acute myeloid leukemia (AML) cases. 

Nov
19
Featured Webinar

Digital PCR for Tag Copy Number Assessment in CRISPR-Edited Cell Lines

Sponsored by
Stilla

Fluorescent proteins or self-labeling tags are invaluable tools for studying protein dynamics in living cells using fluorescence microscopy. However, quantitative imaging requires physiological levels of expression of the target protein of interest (POI), especially when stoichiometric interactions of the POI need to be investigated.

What's Popular?

In Proteomics & Protein Research

  1. Expedeon to Sell Proteomics, Immunology Businesses to Abcam for $130M

  2. Abcam Inks Deal for BrickBio Antibody Conjugation Technology

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.